Related content

The Hypotensive Actions of Osteogenic and Nonosteogenic Parathyroid Hormone Fragments

By Whitfield J. F.   Morley P.   Ross V.   Preston E.   Soska M.   Barbier J.-R.   Isaacs R. J.   Maclean S.   Ohannessian-Barry L.   Willick G. E.  

Calcified Tissue International, Vol. 60, Iss. 3, 1997-03 ,pp. : 302-308

Springer Publishing Company

Access to resources Recommend Favorite

Atorvastatin enhances bone density in ovariectomized rats given 17β-estradiol or human parathyroid hormone(1–34)

By Kawane Tetsuya   Terashima Shinichi   Kurahashi Izuru   Yanagawa Toru   Yoshida Hiroshi   Horiuchi Noboru  

Endocrine Journal, Vol. 24, Iss. 2, 2004-07 ,pp. : 121-129

Humana Press, Inc

Access to resources Recommend Favorite

Daily Treatment of Aged Ovariectomized Rats with Human Parathyroid Hormone (1-84) for 12 Months Reverses Bone Loss and Enhances Trabecular and Cortical Bone Strength

By Fox J.   Miller M.   Newman M.   Metcalfe A.   Turner C.   Recker R.   Smith S.  

Calcified Tissue International, Vol. 79, Iss. 4, 2006-10 ,pp. : 262-272

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Mahon James  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 530-530

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Hampson Geeta  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 531-531

Springer Publishing Company

Access to resources Recommend Favorite